59 results on '"Feuer, Eric J"'
Search Results
2. The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials
3. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
4. On the choice of time scales in competing risks predictions
5. Preliminary estimates of SEER cancer incidence for 2013
6. Early Estimates of SEER Cancer Incidence for 2012: Approaches, Opportunities, and Cautions for Obtaining Preliminary Estimates of Cancer Incidence
7. Models in the Development of Clinical Practice Guidelines
8. Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits
9. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials
10. Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force
11. Secular Trends in Colon and Rectal Cancer Relative Survival
12. Assessing Non–Cancer-Related Health Status of US Cancer Patients: Other-Cause Survival and Comorbidity Prevalence
13. Genetic Simulation Resources: a website for the registration and discovery of genetic data simulators
14. Trends in esophageal adenocarcinoma incidence and mortality
15. The prostate cancer conundrum revisited: Treatment changes and prostate cancer mortality declines
16. The Cancer Survival Query System: Making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients
17. Chapter 3: Cohort Life Tables by Smoking Status, Removing Lung Cancer as a Cause of Death
18. Chapter 1: The Impact of the Reduction in Tobacco Smoking on U.S. Lung Cancer Mortality, 1975–2000: An Introduction to the Problem
19. Chapter 2: Birth-Cohort-Specific Estimates of Smoking Behaviors for the U.S. Population
20. Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000
21. Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence
22. Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortality
23. Projections of the Cost of Cancer Care in the United States: 2010–2020
24. Population-based survival-cure analysis of ER-negative breast cancer
25. State-Based Estimates of Mammography Screening Rates Based on Information from Two Health Surveys
26. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms
27. Breast cancer survivors in the United States: Geographic Variability and Time Trends, 2005-2015
28. Productivity Costs of Cancer Mortality in the United States: 2000–2020
29. Estimates and Projections of Value of Life Lost From Cancer Deaths in the United States
30. A new method to evaluate the completeness of case ascertainment by a cancer registry
31. Improved Survival Time: What Can Survival Cure Models Tell Us About Population-Based Survival Improvements in Late-Stage Colorectal, Ovarian, and Testicular Cancer?
32. Reconstructing Psa Testing Patterns Between Black and White Men in the Us From Medicare Claims and the National Health Interview Survey
33. The Decrease in Breast-Cancer Incidence in 2003 in the United States
34. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000–2020
35. Estimates of long-term survival for newly diagnosed cancer patients: A projection approach
36. Racial/ethnic patterns in lifetime and age-conditional risk estimates for selected cancers
37. Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
38. Modeling the dissemination of mammography in the United States
39. Geographic association between mammography use and mortality reduction in the US
40. An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United States
41. Re: Trends in Use of Adjuvant Multi-Agent Chemotherapy and Tamoxifen for Breast Cancer in the United States: 1975–1999
42. Trends in Use of Adjuvant Multi-Agent Chemotherapy and Tamoxifen for Breast Cancer in the United States: 1975–1999
43. Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
44. Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends
45. Changing Area Socioeconomic Patterns in U.S. Cancer Mortality, 1950–1998: Part I—All Cancers Among Men
46. Projecting SEER cancer survival rates to the US: an ecological regression approach
47. Evaluating the Impact of Population Changes in Diet, Physical Activity, and Weight Status on Population Risk for Colon Cancer (United States)
48. Impact of Screening on Incidence and Mortality of Prostate Cancer in the United States
49. Partitioning linear trends in age-adjusted rates
50. Role of Transurethral Resection of the Prostate in Population-based Prostate Cancer Incidence Rates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.